anti-TL1A antibody (Glenmark)

N/A

Report date: 2025/01/26 18:26:37

Base Information

Drug Nameanti-TL1A antibody (Glenmark)
Drug Alias NameGBR-910
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor superfamily member 15 inhibitors
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGlenmark Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A